CVR number 18278782
Industry 869500

SILKEBORG FYSIOTERAPI OG TRÆNING ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  5.1% 5.8% 7.0% 6.4% 4.8%  
Credit score (0-100)  43 38 34 36 45  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  2,615 2,730 2,918 2,840 2,681  
EBITDA  582 506 626 674 328  
EBIT  436 360 551 660 328  
Pre-tax profit (PTP)  416.5 344.3 535.2 648.3 314.2  
Net earnings  323.7 268.5 417.5 505.7 244.6  
Pre-tax profit without non-rec. items  417 344 535 648 314  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  235 88.9 14.2 0.0 0.0  
Shareholders equity total  676 644 762 967 912  
Interest-bearing liabilities  43.2 0.0 0.0 0.3 0.0  
Balance sheet total (assets)  1,638 1,553 1,704 1,829 1,525  
Net Debt  -523 -553 -911 -1,040 -393  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,615 2,730 2,918 2,840 2,681  
Gross profit growth  -6.4% 4.4% 6.9% -2.7% -5.6%  
Employees  4 5 5 5 5  
Employee growth %  0.0% 25.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,638 1,553 1,704 1,829 1,525  
Balance sheet change%  -30.8% -5.2% 9.8% 7.3% -16.6%  
Added value  582.5 506.3 626.0 734.4 328.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -293 -292 -149 -28 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  5.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  16.7% 13.2% 18.9% 23.2% 12.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  21.8% 22.6% 33.9% 37.6% 19.7%  
ROI %  41.7% 52.1% 78.0% 76.8% 35.2%  
ROE %  31.9% 40.7% 59.4% 58.5% 26.0%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  41.2% 41.5% 44.7% 52.9% 59.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -89.8% -109.2% -145.5% -154.4% -119.7%  
Gearing %  6.4% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  92.6% 75.6% 0.0% 9,231.7% 9,600.6%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.3 1.4 1.6 1.9 2.2  
Current Ratio  1.3 1.4 1.6 1.9 2.2  
Cash and cash equivalent  566.5 553.2 910.7 1,040.6 392.9  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  285.1 397.9 580.1 800.0 744.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  146 101 125 147 66  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  146 101 125 135 66  
EBIT / employee  109 72 110 132 66  
Net earnings / employee  81 54 83 101 49